Immunocore Holdings plc. (IMCR) NASDAQ
$54.32 (1.69) (-3.02%)
Market Cap: $2.73B
As of 05/16/24 03:59 PM EDT. Market closed.
Immunocore Holdings plc. (IMCR)
NASDAQ
$54.32
(1.69) (-3.02%)
Market Cap: $2.73B
As of 05/16/24 03:59 PM EDT. Market closed.
Add to Portfolio
immunocore is a privately owned biotechnology company developing innovative biological therapeutics for the treatment of a range of serious diseases. its world-leading t cell receptor technology exploits the power of the body’s own immune system to find and kill diseased cells. immunocore has established a robust technology platform which combines monoclonal t cell receptor (mtcr) targeting ... read more
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Full Time Employees
480
Address
.
PRICE CHART FOR IMMUNOCORE HOLDINGS PLC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$55.71
Previous Close
$56.01
Days Range
$55.52 - $58.36
52 week range
$42.21 - $76.98
Volume
730,498
Avg. Volume (30 days)
436,316
Market Cap
$2.73B
Dividend Yield
-
P/E
-
Shares Outstanding
48,791,547
Open
$55.71
Previous Close
$56.01
Days Range
$55.52 - $58.36
52 week range
$42.21 - $76.98
Volume
730,498
Avg. Volume (30 days)
436,316
Market Cap
$2.73B
Dividend Yield
-
P/E
-
Shares Outstanding
48,791,547
FINANCIAL STATEMENTS FOR IMMUNOCORE HOLDINGS PLC
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR IMMUNOCORE HOLDINGS PLC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| St Leger Tina Amber | CHIEF HR OFFICER | Apr 01, 2024 | Option Exercise | $29.87 | 4,375 | 130,681 | 4,375 | Apr 03, 2024, 04:15 PM |
| St Leger Tina Amber | CHIEF HR OFFICER | Apr 01, 2024 | Sale | $64.06 | 4,375 | 280,262 | 0 | Apr 03, 2024, 04:15 PM |
| Berman David M | HEAD OF R&D | Feb 28, 2024 | Option Exercise | $17.46 | 36,509 | 637,447 | 36,509 | Mar 01, 2024, 04:15 PM |
| Berman David M | HEAD OF R&D | Feb 28, 2024 | Sale | $68.59 | 36,509 | 2,504,159 | 19,609 | Mar 01, 2024, 04:15 PM |
| Berman David M | HEAD OF R&D | Feb 27, 2024 | Option Exercise | $17.46 | 54,938 | 959,217 | 54,938 | Feb 28, 2024, 04:15 PM |
| Berman David M | HEAD OF R&D | Feb 26, 2024 | Option Exercise | $17.46 | 28,553 | 498,535 | 28,553 | Feb 28, 2024, 04:15 PM |
| Berman David M | HEAD OF R&D | Feb 27, 2024 | Sale | $70.86 | 54,938 | 3,893,030 | 50,490 | Feb 28, 2024, 04:15 PM |
| Berman David M | HEAD OF R&D | Feb 26, 2024 | Sale | $70.65 | 28,553 | 2,017,288 | 2,037 | Feb 28, 2024, 04:15 PM |
| St Leger Tina Amber | Chief HR Officer | Jan 03, 2024 | Option Exercise | $29.87 | 4,375 | 130,681 | 4,375 | Jan 05, 2024, 04:17 PM |
| St Leger Tina Amber | Chief HR Officer | Jan 03, 2024 | Sale | $69.89 | 4,375 | 305,781 | 307 | Jan 05, 2024, 04:17 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| St Leger Tina Amber | CHIEF HR OFFICER | 04/01/2024 | 130,681 |
| St Leger Tina Amber | CHIEF HR OFFICER | 04/01/2024 | 280,262 |
| Berman David M | HEAD OF R&D | 02/28/2024 | 637,447 |
| Berman David M | HEAD OF R&D | 02/28/2024 | 2,504,159 |
| Berman David M | HEAD OF R&D | 02/27/2024 | 959,217 |
| Berman David M | HEAD OF R&D | 02/26/2024 | 498,535 |
| Berman David M | HEAD OF R&D | 02/27/2024 | 3,893,030 |
| Berman David M | HEAD OF R&D | 02/26/2024 | 2,017,288 |
| St Leger Tina Amber | Chief HR Officer | 01/03/2024 | 130,681 |
| St Leger Tina Amber | Chief HR Officer | 01/03/2024 | 305,781 |
Load More Insider Transactions
FUNDS WITH A POSITION IN IMMUNOCORE HOLDINGS PLC
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | 1,515,318 | 1.24% | -39.89% | Other |
| BLACKROCK INC. | 867,357 | 0.00131% | 11.34% | Other |
| RENAISSANCE TECHNOLOGIES LLC | 564,800 | 0.06% | 63.66% | Other |
| CANDRIAM S.C.A. | 189,006 | 0.08% | 31.25% | Other |
| D. E. SHAW & CO., INC. | 140,094 | 0.00779% | 65.49% | Other |
| ALPS ADVISORS INC | 35,135 | 0.02% | 5.23% | Other |
| OCONNOR, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS (LLC) | 28,924 | 0.13% | 4.64% | Value |
| GEODE CAPITAL MANAGEMENT, LLC | 27,045 | 0.00016% | 3.9% | Other |
| UBS OCONNOR LLC | 25,000 (Call) | 0.02% | Exited | Value |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 20,000 | 0.00283% | Exited | Other |
| PENTWATER CAPITAL MANAGEMENT LP | 15,000 | 0.00999% | New | Event Driven |
CHANGE IN SHARES OUTSTANDING FOR IMMUNOCORE HOLDINGS PLC
STOCK BUYBACKS FOR IMMUNOCORE HOLDINGS PLC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 12/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2023
0.40%
1Q
06/30/2023
1.05%
2Q
03/31/2023
1.66%
3Q
12/31/2022
6.94%
4Q
09/30/2022
11.27%
5Q
06/30/2022
11.45%
6Q
03/31/2022
11.46%
7Q
12/31/2021
15.06%
8Q
09/30/2021
11.65%
9Q
06/30/2021
20.00%
10Q
03/31/2021
20.00%
11Q
12/31/2020
20.00%
12Q
09/30/2020
20.00%
13Q
06/30/2020
20.00%
14Q
03/31/2020
20.00%
15Q
12/31/2019
20.00%
16Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR IMMUNOCORE HOLDINGS PLC
LOADING...